Bortezomib injection 2mg

Salvavidas Pharmaceutical Pvt Ltd is a leading supplier and exporter of Bortezomib Injection 2mg in varying strengths and packages. Multiple myeloma and mantle cell lymphoma are treated with bortezomib. It proves its effectiveness by reducing or preventing the growth of cancer cells.

How Bortezomib Injection Works?

Bortezomib injection is an anticancer drug. It works by preventing or reducing intracellular proteolysis. This increases the amount of protein in the cancer cells and causes the cancer cells to die.

What if I forget to take a bortezomib injection of 2mg?

If you forget the dose of Voltenato 2 mg for injection, consult your doctor.

Special precautions for storage:

Store in the refrigerator at 2 ° C to 8 ° C. Keep the vial in the outer box to protect it from light. Storage conditions after dilution of the drug

This medication is used to treat certain types of cancer (such as multiple myeloma, mantle cell lymphoma). It works by slowing or stopping the growth of cancer cells.

In Multiple myeloma Your body destroys bone quicker than it is replaced if you have multiple myeloma. This causes bones to become weak, painful, and prone to breaking. Bortezomib is sometimes used in conjunction with other cancer treatments including chemotherapy. It is an important aspect of your treatment and helps people with multiple myeloma live longer. This drug will eliminate malignant cells and prevent them from spreading.

In Mantle-cell lymphoma Mantle-cell lymphoma, commonly known as non-lymphoma, Hodgkin's is a malignancy of the white blood cells in our bodies. White blood cells are cells that aid in the fight against infection. Bortezomib Injection inhibits the growth of cancer cells while also blocking the activity of other substances necessary for cancer growth and spread. To avoid illness, avoid crowds and wash your hands frequently. Unless your doctor tells you differently, drink plenty of water.

Bortezomib treatment must be started under the supervision of a physician who is familiar with the treatment of cancer patients, but it can also be given by a healthcare worker who is familiar with the use of chemotherapeutic medicines. A healthcare practitioner must prepare Bortezomib 2mg.